Efficacy of catheter ablation in nonparoxysmal atrial fibrillation patients with severe enlarged left atrium and its impact on left atrial structural remodeling

Agnes Pump, Luigi Di Biase, Justin Price, Prasant Mohanty, Rong Bai, Pasquale Santangeli, Sanghamitra Mohanty, Chintan Trivedi, Rachel Yan, Rodney Horton, Javier E. Sanchez, Jason Zagrodzky, Shane Bailey, G. Joseph Gallinghouse, J. David Burkhardt, Andrea Natale

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

AF Ablation in Patients with Large LA Introduction The effect of catheter ablation on severe left atrial enlargement especially in nonparoxysmal atrial fibrillation (NPAF) patients is not well understood. Whether reverse remodelling may occur after ablation has not been evaluated in this setting. Methods and results Fifty consecutive patients with left atrial diameter (LAD) ≥50 mm, and LA volume >200 cc undergoing catheter ablation for drug-refractory NPAF were included in this study. Transthoracic echocardiographic measurements were performed at baseline and at 12-months postprocedure. Left ventricular end-diastolic and end-systolic dimensions were indexed by body surface area (LVEDDI, LVESDI). Electroanatomic mapping system (Carto or NavX system) and computed tomography (CT) were used for 3-dimensional reconstruction of the LA. All patients underwent posterior wall isolation and pulmonary vein (PV) antrum and extra PV trigger ablations. Long-term follow-up was monitored by event recordings, 7-day Holter monitors and office visits. The mean age was 65 ± 10 years, 78% male, persistent AF 22 (44%), longstanding AF 28 (56%), LAD diameter 56.9 ± 7.8 mm, left ventricular ejection fraction (LVEF) 53 ± 14 and median AF duration 72 (49-96) months. At 12-month follow-up, 27 patients (54%) remained arrhythmia-free off antiarrhythmic drugs. Significant reduction in LAD at follow-up (≥10% reduction) was observed in 52% (26/50) of the total population and among the 63% (17/27) of recurrence-free patients. Magnitude of LA reduction was identically distributed among the persistent and longstanding persistent AF cohorts (16 ± 12% vs 14 ± 16%, respectively, P = 0.15). A significant 20% improvement in LVEF (from 53 ± 14 to 58 ± 9, P = 0.03) was found in the overall population. Improvement was noted in recurrence-free patients. No significant change in LVEDDI and LVESDI was noted. After adjusting for baseline risk factors in a multivariable model, a reduction in LAD was identified as a strong predictor of long-term success (beta = -11.1, P = 0.013). Preexisting LA scarring was associated with increased LAD (beta = 2.7, P = 0.023). No periprocedural or long-term complications were reported. Conclusion Our results show that atrial fibrillation ablation is effective in NPAF patients with severe LA enlargement and is associated with LA reverse remodeling and improvement in LVEF.

Original languageEnglish (US)
Pages (from-to)1224-1231
Number of pages8
JournalJournal of Cardiovascular Electrophysiology
Volume24
Issue number11
DOIs
StatePublished - Nov 2013

Fingerprint

Atrial Remodeling
Catheter Ablation
Heart Atria
Atrial Fibrillation
Stroke Volume
Pulmonary Veins
Office Visits
Recurrence
Body Surface Area
Anti-Arrhythmia Agents
Population
Cicatrix
Cardiac Arrhythmias
Tomography

Keywords

  • atrial fibrillation
  • catheter ablation
  • left atrial enlargement
  • long-lasting persistent atrial fibrillation
  • pulmonary vein isolation

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Efficacy of catheter ablation in nonparoxysmal atrial fibrillation patients with severe enlarged left atrium and its impact on left atrial structural remodeling. / Pump, Agnes; Di Biase, Luigi; Price, Justin; Mohanty, Prasant; Bai, Rong; Santangeli, Pasquale; Mohanty, Sanghamitra; Trivedi, Chintan; Yan, Rachel; Horton, Rodney; Sanchez, Javier E.; Zagrodzky, Jason; Bailey, Shane; Gallinghouse, G. Joseph; Burkhardt, J. David; Natale, Andrea.

In: Journal of Cardiovascular Electrophysiology, Vol. 24, No. 11, 11.2013, p. 1224-1231.

Research output: Contribution to journalArticle

Pump, A, Di Biase, L, Price, J, Mohanty, P, Bai, R, Santangeli, P, Mohanty, S, Trivedi, C, Yan, R, Horton, R, Sanchez, JE, Zagrodzky, J, Bailey, S, Gallinghouse, GJ, Burkhardt, JD & Natale, A 2013, 'Efficacy of catheter ablation in nonparoxysmal atrial fibrillation patients with severe enlarged left atrium and its impact on left atrial structural remodeling', Journal of Cardiovascular Electrophysiology, vol. 24, no. 11, pp. 1224-1231. https://doi.org/10.1111/jce.12253
Pump, Agnes ; Di Biase, Luigi ; Price, Justin ; Mohanty, Prasant ; Bai, Rong ; Santangeli, Pasquale ; Mohanty, Sanghamitra ; Trivedi, Chintan ; Yan, Rachel ; Horton, Rodney ; Sanchez, Javier E. ; Zagrodzky, Jason ; Bailey, Shane ; Gallinghouse, G. Joseph ; Burkhardt, J. David ; Natale, Andrea. / Efficacy of catheter ablation in nonparoxysmal atrial fibrillation patients with severe enlarged left atrium and its impact on left atrial structural remodeling. In: Journal of Cardiovascular Electrophysiology. 2013 ; Vol. 24, No. 11. pp. 1224-1231.
@article{d54ac74c138e470a92716e27741151b2,
title = "Efficacy of catheter ablation in nonparoxysmal atrial fibrillation patients with severe enlarged left atrium and its impact on left atrial structural remodeling",
abstract = "AF Ablation in Patients with Large LA Introduction The effect of catheter ablation on severe left atrial enlargement especially in nonparoxysmal atrial fibrillation (NPAF) patients is not well understood. Whether reverse remodelling may occur after ablation has not been evaluated in this setting. Methods and results Fifty consecutive patients with left atrial diameter (LAD) ≥50 mm, and LA volume >200 cc undergoing catheter ablation for drug-refractory NPAF were included in this study. Transthoracic echocardiographic measurements were performed at baseline and at 12-months postprocedure. Left ventricular end-diastolic and end-systolic dimensions were indexed by body surface area (LVEDDI, LVESDI). Electroanatomic mapping system (Carto or NavX system) and computed tomography (CT) were used for 3-dimensional reconstruction of the LA. All patients underwent posterior wall isolation and pulmonary vein (PV) antrum and extra PV trigger ablations. Long-term follow-up was monitored by event recordings, 7-day Holter monitors and office visits. The mean age was 65 ± 10 years, 78{\%} male, persistent AF 22 (44{\%}), longstanding AF 28 (56{\%}), LAD diameter 56.9 ± 7.8 mm, left ventricular ejection fraction (LVEF) 53 ± 14 and median AF duration 72 (49-96) months. At 12-month follow-up, 27 patients (54{\%}) remained arrhythmia-free off antiarrhythmic drugs. Significant reduction in LAD at follow-up (≥10{\%} reduction) was observed in 52{\%} (26/50) of the total population and among the 63{\%} (17/27) of recurrence-free patients. Magnitude of LA reduction was identically distributed among the persistent and longstanding persistent AF cohorts (16 ± 12{\%} vs 14 ± 16{\%}, respectively, P = 0.15). A significant 20{\%} improvement in LVEF (from 53 ± 14 to 58 ± 9, P = 0.03) was found in the overall population. Improvement was noted in recurrence-free patients. No significant change in LVEDDI and LVESDI was noted. After adjusting for baseline risk factors in a multivariable model, a reduction in LAD was identified as a strong predictor of long-term success (beta = -11.1, P = 0.013). Preexisting LA scarring was associated with increased LAD (beta = 2.7, P = 0.023). No periprocedural or long-term complications were reported. Conclusion Our results show that atrial fibrillation ablation is effective in NPAF patients with severe LA enlargement and is associated with LA reverse remodeling and improvement in LVEF.",
keywords = "atrial fibrillation, catheter ablation, left atrial enlargement, long-lasting persistent atrial fibrillation, pulmonary vein isolation",
author = "Agnes Pump and {Di Biase}, Luigi and Justin Price and Prasant Mohanty and Rong Bai and Pasquale Santangeli and Sanghamitra Mohanty and Chintan Trivedi and Rachel Yan and Rodney Horton and Sanchez, {Javier E.} and Jason Zagrodzky and Shane Bailey and Gallinghouse, {G. Joseph} and Burkhardt, {J. David} and Andrea Natale",
year = "2013",
month = "11",
doi = "10.1111/jce.12253",
language = "English (US)",
volume = "24",
pages = "1224--1231",
journal = "Journal of Cardiovascular Electrophysiology",
issn = "1045-3873",
publisher = "Wiley-Blackwell",
number = "11",

}

TY - JOUR

T1 - Efficacy of catheter ablation in nonparoxysmal atrial fibrillation patients with severe enlarged left atrium and its impact on left atrial structural remodeling

AU - Pump, Agnes

AU - Di Biase, Luigi

AU - Price, Justin

AU - Mohanty, Prasant

AU - Bai, Rong

AU - Santangeli, Pasquale

AU - Mohanty, Sanghamitra

AU - Trivedi, Chintan

AU - Yan, Rachel

AU - Horton, Rodney

AU - Sanchez, Javier E.

AU - Zagrodzky, Jason

AU - Bailey, Shane

AU - Gallinghouse, G. Joseph

AU - Burkhardt, J. David

AU - Natale, Andrea

PY - 2013/11

Y1 - 2013/11

N2 - AF Ablation in Patients with Large LA Introduction The effect of catheter ablation on severe left atrial enlargement especially in nonparoxysmal atrial fibrillation (NPAF) patients is not well understood. Whether reverse remodelling may occur after ablation has not been evaluated in this setting. Methods and results Fifty consecutive patients with left atrial diameter (LAD) ≥50 mm, and LA volume >200 cc undergoing catheter ablation for drug-refractory NPAF were included in this study. Transthoracic echocardiographic measurements were performed at baseline and at 12-months postprocedure. Left ventricular end-diastolic and end-systolic dimensions were indexed by body surface area (LVEDDI, LVESDI). Electroanatomic mapping system (Carto or NavX system) and computed tomography (CT) were used for 3-dimensional reconstruction of the LA. All patients underwent posterior wall isolation and pulmonary vein (PV) antrum and extra PV trigger ablations. Long-term follow-up was monitored by event recordings, 7-day Holter monitors and office visits. The mean age was 65 ± 10 years, 78% male, persistent AF 22 (44%), longstanding AF 28 (56%), LAD diameter 56.9 ± 7.8 mm, left ventricular ejection fraction (LVEF) 53 ± 14 and median AF duration 72 (49-96) months. At 12-month follow-up, 27 patients (54%) remained arrhythmia-free off antiarrhythmic drugs. Significant reduction in LAD at follow-up (≥10% reduction) was observed in 52% (26/50) of the total population and among the 63% (17/27) of recurrence-free patients. Magnitude of LA reduction was identically distributed among the persistent and longstanding persistent AF cohorts (16 ± 12% vs 14 ± 16%, respectively, P = 0.15). A significant 20% improvement in LVEF (from 53 ± 14 to 58 ± 9, P = 0.03) was found in the overall population. Improvement was noted in recurrence-free patients. No significant change in LVEDDI and LVESDI was noted. After adjusting for baseline risk factors in a multivariable model, a reduction in LAD was identified as a strong predictor of long-term success (beta = -11.1, P = 0.013). Preexisting LA scarring was associated with increased LAD (beta = 2.7, P = 0.023). No periprocedural or long-term complications were reported. Conclusion Our results show that atrial fibrillation ablation is effective in NPAF patients with severe LA enlargement and is associated with LA reverse remodeling and improvement in LVEF.

AB - AF Ablation in Patients with Large LA Introduction The effect of catheter ablation on severe left atrial enlargement especially in nonparoxysmal atrial fibrillation (NPAF) patients is not well understood. Whether reverse remodelling may occur after ablation has not been evaluated in this setting. Methods and results Fifty consecutive patients with left atrial diameter (LAD) ≥50 mm, and LA volume >200 cc undergoing catheter ablation for drug-refractory NPAF were included in this study. Transthoracic echocardiographic measurements were performed at baseline and at 12-months postprocedure. Left ventricular end-diastolic and end-systolic dimensions were indexed by body surface area (LVEDDI, LVESDI). Electroanatomic mapping system (Carto or NavX system) and computed tomography (CT) were used for 3-dimensional reconstruction of the LA. All patients underwent posterior wall isolation and pulmonary vein (PV) antrum and extra PV trigger ablations. Long-term follow-up was monitored by event recordings, 7-day Holter monitors and office visits. The mean age was 65 ± 10 years, 78% male, persistent AF 22 (44%), longstanding AF 28 (56%), LAD diameter 56.9 ± 7.8 mm, left ventricular ejection fraction (LVEF) 53 ± 14 and median AF duration 72 (49-96) months. At 12-month follow-up, 27 patients (54%) remained arrhythmia-free off antiarrhythmic drugs. Significant reduction in LAD at follow-up (≥10% reduction) was observed in 52% (26/50) of the total population and among the 63% (17/27) of recurrence-free patients. Magnitude of LA reduction was identically distributed among the persistent and longstanding persistent AF cohorts (16 ± 12% vs 14 ± 16%, respectively, P = 0.15). A significant 20% improvement in LVEF (from 53 ± 14 to 58 ± 9, P = 0.03) was found in the overall population. Improvement was noted in recurrence-free patients. No significant change in LVEDDI and LVESDI was noted. After adjusting for baseline risk factors in a multivariable model, a reduction in LAD was identified as a strong predictor of long-term success (beta = -11.1, P = 0.013). Preexisting LA scarring was associated with increased LAD (beta = 2.7, P = 0.023). No periprocedural or long-term complications were reported. Conclusion Our results show that atrial fibrillation ablation is effective in NPAF patients with severe LA enlargement and is associated with LA reverse remodeling and improvement in LVEF.

KW - atrial fibrillation

KW - catheter ablation

KW - left atrial enlargement

KW - long-lasting persistent atrial fibrillation

KW - pulmonary vein isolation

UR - http://www.scopus.com/inward/record.url?scp=84886801743&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886801743&partnerID=8YFLogxK

U2 - 10.1111/jce.12253

DO - 10.1111/jce.12253

M3 - Article

C2 - 24020717

AN - SCOPUS:84886801743

VL - 24

SP - 1224

EP - 1231

JO - Journal of Cardiovascular Electrophysiology

JF - Journal of Cardiovascular Electrophysiology

SN - 1045-3873

IS - 11

ER -